BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• FDA

  Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication

  Bausch + Lomb announced that the U.S. Food and Drug Administration (FDA) has approved the Bausch + Lomb ULTRA® family of contact lenses for extended wear of up to six nights and seven days of continuous wear.

  May 2, 2018

   · 

  4 min read
• Kimchi, found useful in preventing allergic diseases, such as atopic dermatitis, asthma, and rhinitis, is a key staple in Korean cuisine

  Kimchi, one of Korea’s major fermented foods, is helpful in preventing allergic diseases (eg, atopic dermatitis, asthma, and rhinitis), obesity, and anemia, according to a new paper.

  May 2, 2018

   · 

  5 min read
• Job Trends

  The Pivotal Trial Results on Ampion™ (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal

  Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the publication entitled: “Intra-articular injection of the anti-inflammatory compound LMWF-5A (Ampion™) in adults with severe osteoarthritis: a double-blind prospective randomized controlled multicenter safety and efficacy trial”

  May 2, 2018

   · 

  4 min read
• Business

  NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California

  NanoSphere Health Sciences INC has joined forces with Vertical™, the largest fully integrated company in the legal medical cannabis industry, to launch Evolve’s growing product line in Arizona and California this summer.

  May 2, 2018

   · 

  6 min read
• Business

  Aquestive Therapeutics Appoints Nancy Lurker to Board of Directors

  Appointment strengthens CNS product portfolio commercialization expertise

  May 2, 2018

   · 

  2 min read
• Biotech Bay

  Refuge Biotechnologies Completes $25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology

  Refuge Biotechnologies, Inc. announced the closing of a $25 million Series B investment round.

  May 2, 2018

   · 

  7 min read
• BioMidwest

  Astronomer Announces Secure, Private Cloud Option for Running Apache Airflow on Kubernetes

  Astronomer has launched its Enterprise Edition, allowing for easy Apache Airflow deployment in a secure environment.

  May 2, 2018

   · 

  3 min read
• Business

  C4X Discovery Holdings plc: Collaboration with e-Therapeutics to identify novel mechanisms for the treatment of Parkinson’s Disease

  C4X Discovery Holdings plc announces that it has entered into a joint research collaboration with e-Therapeutics plc (AIM: ETX) to identify novel mechanistic insights into Parkinson’s Disease (PD).

  May 2, 2018

   · 

  4 min read
• Business

  Mologic Signs Agreements with Medisur and Peripal to Distribute PERiPLEX POC Diagnostic in Europe

  Mologic Ltd announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®.

  May 2, 2018

   · 

  4 min read
• Deals

  LGC acquires BioAutomation Corporation

  LGC has announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of BioAutomation Corporation (BioAutomation), manufacturer of the renowned MerMade oligo synthesis instruments.

  May 2, 2018

   · 

  3 min read